Issue highlights:
- CX 2025 preview: Global vascular community is London bound for Challenges update
- A year in profiles: Highlights from interviews with Bijan Modarai, Kevin Mani, Ramon Varcoe and Vincent Rowe
- Does Medtronic’s decision to discontinue offering Ellipsys signal the end of endoAVF?
- Multidisciplinary, multi-stakeholder efforts key to setting venous disease research priorities, Ulka Sachdev-Ost (Pittsburgh, USA) tells EVC 2025
